Clinical studies show that the CLENZIderm M.D. Normal to Oily System significantly reduces follicular P. acnes bacteria compared to a leading BPO/clindamycin combination. Reduction in follicular P. acnes was apparent immediately after a single application and sustained improvement through eight hours. The Normal to Oily System is clinically proven to provide fast clearance of inflammatory and non-inflammatory acne lesions for results your patients can see and feel.
Effectively Used Once Daily
The CLENZIderm M.D. Normal to Oily System can also be used effectively once daily.*
The CLENZIderm M.D. Normal to Dry System is clinically proven to provide fast clearance of inflammatory and non-inflammatory acne lesions while minimizing dryness and maximizing patient comfort.
In a recent clinical study, the following results were reported after 2 weeks of once-daily application:
- 49% reduction in inflammatory lesions
- 35% reduction in non-inflammatory lesions
Easy-to-Use, Well-Tolerated System
As a lotion-based system containing 20% glycerin and 1% dimethicone, the CLENZIderm M.D. Normal to Dry System is clinically proven to provide less drying and better overall comfort than the leading topical prescription BPO/clindamycin combination in an optimized emollient vehicle, according to a recent clinical study†:
- No patients reported dryness at Week 3 with CLENZIderm M.D.
- 91% of patients rated CLENZIderm M.D. as “Very Comfortable” at Week 3